Summit Therapeutics
SMMT
#1524
Rank
โ‚น1.229 T
Marketcap
โ‚น1,651
Share price
-2.66%
Change (1 day)
4.51%
Change (1 year)

Summit Therapeutics (SMMT) - Net assets

Net assets on the balance sheet as of September 2025 : โ‚น17.33 Billion

According to Summit Therapeutics 's latest financial reports the company has โ‚น17.33 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Summit Therapeutics - Net assets on balance sheet (from 2020 to 2020)

Net assets by year

Year Net assets Change
2024-12-31$โ‚น33.34 B415.62%
2023-12-31$โ‚น6.46 B-38.29%
2022-12-31$โ‚น10.48 B69.07%
2021-12-31$โ‚น6.19 B6.68%
2020-12-31$โ‚น5.81 B
2019-01-31$โ‚น5.20 B-1392.25%
2018-01-31$-โ‚น0.41 Billion8.81%
2017-01-31$-โ‚น0.38 Billion-116.72%
2016-01-31$โ‚น2.21 B21.41%
2015-01-31$โ‚น1.82 B125.87%
2014-01-31$โ‚น0.80 B112.95%
2013-01-31$โ‚น0.37 B21.72%
2012-01-31$โ‚น0.31 B-26.23%
2011-01-31$โ‚น0.42 B-56.73%
2010-01-31$โ‚น0.97 B13.24%
2009-01-31$โ‚น0.86 B-79.63%
2008-01-31$โ‚น4.23 B22.11%
2007-01-31$โ‚น3.46 B89.88%
2006-01-31$โ‚น1.82 B-16.36%
2005-01-31$โ‚น2.18 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sarepta Therapeutics
SRPT
โ‚น119.03 B 586.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
โ‚น19.98 B 15.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
โ‚น7.91 B-54.35%๐Ÿ‡บ๐Ÿ‡ธ USA